Vinge has, together with Kirkland & Ellis, advised Blue Wolf Capital Partners LLC (“Blue Wolf”), a middle market private equity firm specializing in the healthcare and industrial sectors, in connection with the acquisition of seven manufacturing and development facilities in Sweden, France, and Spain, from Recipharm Group, a contract development and manufacturing organization (“CDMO”) headquartered in Stockholm.
Vinge has advised Ingrid Capacity in connection with the entering into a strategic partnership with Locus Energy, a leading Nordic energy infrastructure company owned by SEB Asset Management's fund SEB Nordic Energy.
Vinge has advised Fidelio Capital (“Fidelio”) and the other shareholders of Odevo Group (“Odevo”) in connection with the divestment of a minority shareholding to funds controlled by CVC Capital Partners (“CVC”). Fidelio, the existing management team and other minority shareholders of Odevo will retain a majority holding in the company.
Vinge has advised IK Partners and the other owners in connection with the divestment of Carspect Group Holding AB to TÜV SÜD Aktiengesellschaft. Carspect is a leading provider of vehicle inspections in Sweden, Estonia and Latvia, with a total of approximately 150 stations and over 500 employees.
Vinge advises Bridgepoint Development Capital III and Bridgepoint Europe VI (”Bridgepoint”), founders as well as the other shareholders in connection with Cinven, an international private equity firm, acquiring a significant stake in Vitamin Well Group (“Vitamin Well”) and thereby becoming the new lead investor, while Bridgepoint, founders and the other shareholders will retain significant minority stakes following the transaction.
Vinge has advised Embracer Group in connection with a EUR 600 million multicurrency revolving facility agreement entered into with BNP Paribas, Citibank Europe, DNB, JP Morgan, Nordea, SEB and Swedbank.
Vinge has advised SmartCella Holding AB in connection with its fund raising of EUR 50 million. The capital was invested by, among others, AstraZeneca, the Fourth Swedish National Pension Fund, AMF Pension, SEB-Stiftelsen, Handelsbanken Fonder and RoosGruppen AB. SmartCella is a world-leading biotechnology company pioneering the future of targeted therapies by combining first-in-class delivery platforms with cutting-edge cell and gene therapies.
Vinge advises Bergs Timber AB (publ) and Bitus AB in connection with the divestment of the Fågelfors pellets business to J. Rettenmeier & Söhne. The Fågelfors pellets factory is based in Fågelfors in Högsby. The acquisition is subject to customary regulatory approvals.
Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elektro-Emanuel AB. The company carries out electrical installations for both companies and private individuals and has offices in four cities in western Sweden.
Vinge, together with Thommessen, advised the infrastructure group Eleda in connection with the acquisition of Sartor & Drange AS, a market-leading civil engineering contractor in the Bergen region. Sartor & Drange AS offers services in areas such as road, water and sewerage and foundation work in Western Norway. Sartor & Drange AS has approximately 200 employees and a turnover of approximately NOK 1,100 million.
The energy storage facility Bredhälla consists of batteries utilizing lithium-ion technology with a total capacity of 42,5MW /42,5MWh spread across 20 modules, making it the largest battery park in Sweden. Bredhälla will provide ancillary services to Svenska Kraftnät to ensure stability in the electricity grid and participate in wholesale markets by providing energy arbitrage.
Vinge advises Axcel V in connection with the sale of Loopia Group to team.blue, Europe’s leading digital enabler for entrepreneurs and SMBs and backed by Hg, a leading investor in European and transatlantic software and services businesses.